Exploring the genomic landscape of hepatobiliary cancers to establish a novel molecular subtype classification.

Authors

null

Anthony Joseph Scholer

John Wayne Cancer Institute at Providence St. John’s Health Center, Santa Monica, CA

Anthony Joseph Scholer , Mary Garland-Kledzik , Debopyria Ghosh , Juan Santamaria-Barria , Adam Khader , Javier Orozco , Melanie Goldfarb , Diego M. Marzese

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 562)

Abstract #

562

Poster Bd #

E1

Abstract Disclosures

Similar Posters

Poster

2019 Genitourinary Cancers Symposium

Non-urothelial bladder cancer: Genomic alterations and patient outcomes.

Non-urothelial bladder cancer: Genomic alterations and patient outcomes.

First Author: Fern Anari

Poster

2019 Gastrointestinal Cancers Symposium

Genomic alterations in appendiceal carcinoma using circulating DNA.

Genomic alterations in appendiceal carcinoma using circulating DNA.

First Author: Walid Labib Shaib

Poster

2015 Gastrointestinal Cancers Symposium

Comprehensive genomic profiling of cancer of the appendix to reveal new routes to targeted therapies.

Comprehensive genomic profiling of cancer of the appendix to reveal new routes to targeted therapies.

First Author: Daniel A. Goldstein

Poster

2014 Gastrointestinal Cancers Symposium

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).

First Author: Rachna T. Shroff